Skip to main content
Clinical Trials/RBR-2x6hmbv
RBR-2x6hmbv
Not yet recruiting
未知

Consequences of Sars-Covid19 on the cardiovascular autonomic control of hypertensive patients

Faculdade de Medicina de Ribeirão Preto - FMRP/USP0 sitesOctober 14, 2022

Overview

Phase
未知
Intervention
Not specified
Conditions
COVID-19
Sponsor
Faculdade de Medicina de Ribeirão Preto - FMRP/USP
Status
Not yet recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
October 14, 2022
End Date
March 1, 2026
Last Updated
2 years ago
Study Type
Intervention
Sex
Male

Investigators

Sponsor
Faculdade de Medicina de Ribeirão Preto - FMRP/USP

Eligibility Criteria

Inclusion Criteria

  • Homens; hipertensos ou normotensos; idade entre 35 e 55 anos; acometidos por COVID\-19 entre 6 e 24 meses antes; assintomático, leve ou internados em enfermaria por baixa saturação de oxigênio

Exclusion Criteria

  • Smokers; diagnosis of cognitive disturbances, musculoskeletal disorders, and chronic diseases; during the period of transmission of the Covid\-19 disease; patients who had the severe form and required ICU admission; previous home or outpatient physical therapy treatment; current use of drugs that interfere with cardiac functionality and cardiovascular autonomic control

Outcomes

Primary Outcomes

Not specified

Similar Trials